Remember Covid? Three years ago we were all hunkered down at home sheltering in place. Many businesses were closed, schools cancelled all in-person classes and social gatherings were taboo (if not illegal). Any time you left the house masks were required. It still amuses me seeing cars drive down the street with the driver alone in the car wearing a mask. I recall running errands to Kroger, Home Depot, Walmart, Lowes and the few other stores that were open and everyone was wearing masks. Retail establishments also required social distancing, asking people to stand at least six feet apart.
Category: Policy & Legislation
Health Sharing Ministries Popular with Many (but not all)
Health care sharing ministries have been around for years, and they fill a niche in a diverse insurance market shattered by Obamacare. The Affordable Care Act (Obamacare) has provisions that allow sharing ministries to coexist with Obamacare plans, which makes many consumers happy, but irritates some Obamacare advocates. It’s been a year since I last wrote…
Saturday Links
- A benefit of wildfires: they make temperatures unseasonably cool.
- Study: CMS delay in approving treatments for Alzheimer’s disease impose a social cost ranging from $13.1 billion to $545.6 billion. Part of these losses stems from increased private and public healthcare spending ranging from $6.8 billion to $284.5 billion.
- Hospital finances: profits and cash reserves are up; charity care is not.
- Another SS horror story: Social Security demands return of $6,000 from an 81-year-old widow for mistaken payment 45 years ago.
Biden’s Cancer Moonshot Cancelled
What if we could detect almost all cancers in the earliest stages when less-invasive treatments mean lifesaving cures? The answer: Mortality rates — and health care costs — would plummet because most cancers could be cured or controlled using existing therapies.
The good news is this innovation exists today in the form of multi-cancer early detection (MCED) from one blood test. The bad news is we don’t have an Eisenhower administration determined to deliver a medical game-changer to as many Americans as possible.
Instead, we have a Biden administration — in the form of the Federal Trade Commission and Chair Lina Khan that Biden named to head it — standing in the way and creating an impenetrable barrier to access to millions of cancer patients.